coin-img-ETHETH+0.09%coin-img-BTCBTC+0.25%coin-img-SOLSOL-0.01%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.73%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+3.05%coin-img-GRAMTONGRAMTON-1.92%coin-img-ETHETH+0.09%coin-img-BTCBTC+0.25%coin-img-SOLSOL-0.01%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.73%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+3.05%coin-img-GRAMTONGRAMTON-1.92%coin-img-ETHETH+0.09%coin-img-BTCBTC+0.25%coin-img-SOLSOL-0.01%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.73%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+3.05%coin-img-GRAMTONGRAMTON-1.92%coin-img-ETHETH+0.09%coin-img-BTCBTC+0.25%coin-img-SOLSOL-0.01%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.73%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+3.05%coin-img-GRAMTONGRAMTON-1.92%

Morepen Laboratories posts record Q1 FY27 revenue and profit; EBITDA jumps 207%, PAT surges 394%; CDMO moves to full commercial scale

AI Market Summary
Morepen Laboratories reported record Q1'FY27 results with revenue up 34% YoY, EBITDA up 207% and PAT up 394%, alongside an 82.5bn INR CDMO order moving into full commercialization. The update signals stronger execution in contract manufacturing and API exports, but it is an idiosyncratic single-stock development with limited read-through to the broader listed universe and no direct linkage to crypto assets.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+1.25%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Morepen Laboratories reported its Q1 FY27 results for the quarter ended June 30, 2026, delivering its highest-ever quarterly performance. Revenue rose 34% year-on-year to Rs 575.31 crore, while net profit climbed 394% to Rs 56.35 crore. EBITDA stood at Rs 87.72 crore, up 207% from a year earlier, and the EBITDA margin expanded to 15.25% from 6.65%. The company said its Rs 825 crore CDMO order has entered full-scale commercialization, with Rs 58 crore of commercial deliveries completed during the quarter. Management attributed the sharp improvement to meaningful progress in contract development and manufacturing as well as a stronger contribution from API exports.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.